*Retrovirology*as a medical study first emerged in the early 1900s. In 1908, Ellermann and Bang reported on the transmissibility of avian leucosis by cell-free filtrates, suggesting the involvement of a virus \[[@B1]\]. Shortly afterward, in 1910, Rous demonstrated that chicken sarcomas were infectious and when inoculated into healthy birds induced tumors \[[@B2]\]. Today, a plethora of oncogenic animal retroviruses including bovine leukemia virus, feline leukemia virus, gibbon ape leukemia virus, Jaagsiektse sheep retrovirus, murine leukemia virus, mouse mammary tumor virus, reticuloendotheliosis virus, simian T-cell lymphotropic virus, and Walleye dermal sarcoma virus has been described.

Understanding how retroviruses cause cancer took a major step forward with the development of the cellular oncogene hypothesis in 1976. Thus Varmus, Bishop and colleagues \[[@B3]\] demonstrated that the viral oncogenes (*v-onc*) encoded by many retroviruses were captured originally from cellular sequences (i.e. *c-onc*). To date, three general models of retroviral transformation are accepted: a) over-expression of *v-onc*; b) *cis*-oncogenic effect from promoter insertion; and c) *cis*-oncogenic effect from enhancer insertion (Fig. [1A, B, C](#F1){ref-type="fig"}).

![Panels A, B, and C show the three accepted ways by which a retrovirus may transform cells: capture of a *c-onc*and over-expression of *v-onc*by the provirus (A); promoter insertion upstream of a growth controlling cellular gene (B); and enhancer insertions either upstream or downstream of growth controlling cellular genes (C). Panel D shows the stepwise ways in which HTLV-I Tax oncoprotein may transform cells by i) inactivating checkpoints to induce tolerance of damaged DNA, and ii) permitting the accumulation of unrepaired DNA lesions which ultimately convert a normal cell to a transformed cell.](1742-4690-2-15-1){#F1}

Although not yet fully understood, HTLV-I is believed to transform human T-cells neither through the acquisition of a *c-onc*nor by *cis*-insertion effects on the cellular genome. Pioneering molecular biology studies by Mitsuaki Yoshida and colleagues led to the delineation of the HTLV-I transforming gene, *Tax*\[[@B4]\]. Tax has no cellular homologue; and it works in *trans*to disrupt cellular checkpoints and destabilize genome integrity \[[@B5]\] leading to transformation (Fig. [1D](#F1){ref-type="fig"}). A more extensive discussion of the molecular biology of HTLV-I and its transforming function will be in an upcoming comprehensive review by Masao Matsuoka to be published in *Retrovirology*.

Two articles in this month\'s Retrovirology describe respectively the discovery of adult T-cell leukemia \[[@B6]\] and HTLV-I \[[@B7]\].
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